Insider Transactions in Q1 2022 at Invo Bioscience, Inc. (INVO)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 15
2022
|
Andrea Goren Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,361
+23.09%
|
-
|
|
Jan 15
2022
|
Barbara Ryan Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,588
+28.97%
|
-
|
|
Jan 15
2022
|
Rebecca Messina Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,311
+38.68%
|
-
|
|
Jan 15
2022
|
Matthew K Szot Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,250
+29.33%
|
-
|
|
Jan 15
2022
|
Steve Shum Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,111
+19.69%
|
-
|
|
Jan 15
2022
|
Michael Jos. Campbell Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,236
+18.93%
|
-
|
|
Jan 15
2022
|
Jeffrey Segal Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,034
+30.85%
|
-
|
|
Jan 15
2022
|
Kevin Doody Medical Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,480
+4.05%
|
-
|
|
Jan 15
2022
|
Trent D Davis Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,865
+28.32%
|
-
|